ADMA Biologics is a leading Contract Manufacturing Organisation (CMO) and Contract Development and Manufacturing Organisation (CDMO) that focuses on finished dosage formulation services tailored for the pharmaceutical industry. With in-house aseptic fill-finish capabilities supported by an FDA-approved process, ADMA Biologics offers both clinical stage and commercial clients the speed and flexibility required to meet the needs of caregivers and patients. Their advanced aseptic filling process employs a state-of-the-art closed isolator design, minimising human intervention and ensuring the production of safe and reliable drug products.

Services include:
– Finished Dosage Forms
– Aseptic Fill-Finish Services
– Container Closure Systems
– Customisation of Presentation Sizes and Volumes

ADMA Biologics continues to provide innovative solutions and reliable services to enhance the pharmaceutical landscape. For more information, please visit admabiologics.com.